Selberherr Andreas, Scheuba Christian, Riss Philipp, Niederle Bruno
Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University, Vienna, Austria.
Section of Endocrine Surgery, Division of General Surgery, Department of Surgery, Medical University, Vienna, Austria.
Surgery. 2015 Feb;157(2):349-53. doi: 10.1016/j.surg.2014.09.007. Epub 2014 Dec 19.
To describe a standardized, efficient, and cost-effective protocol for the diagnosis of temporary/persisting postoperative hypoparathyroidism after (total) thyroidectomy.
We included 237 consecutive patients who underwent (total) thyroidectomy without central neck dissection for various indications. Serum calcium (sCa) and intact parathyroid hormone (iPTH) levels were measured prospectively on the morning of postoperative day 1 to predict the long-term parathyroid metabolism. On the morning of postoperative day 2, measurements were repeated. Follow-up was performed at 1 and 6 months postoperatively.
On the morning of postoperative day 1, patients with iPTH ≥ 15 pg/mL (178/237; 75%) and sCa > 2.0 mmol/L were normocalcemic, and "normal" parathyroid metabolism was predicted. iPTH levels of <10 pg/mL and sCa levels of ≤2.0 mmol/L were present in 33 of the 237 patients ("disturbed" parathyroid metabolism; 14%). A "gray zone" included patients with "uncertain" parathyroid metabolism demonstrating iPTH levels between 10 and 15 pg/mL (26/237; 11%). Patients with "disturbed" and "uncertain" parathyroid metabolism were given oral calcium and vitamin D. On the morning of the second postoperative day, iPTH turned to "normal" in 10 of those 26 (38%) patients, and no further calcium or vitamin D was given. During follow-up, supplemental calcium and vitamin D was able to be stopped in all but 2 patients ("permanent" hypoparathyroidism; 2/237; 0.8%).
Measurement of iPTH on the morning after operation allows accurate prediction of postoperative parathyroid function in ≥99% of cases. This simple recommendation is practicable in all surgical units, and is an efficient and cost-effective way to recognize patients who require calcium and vitamin D supplementation.
描述一种标准化、高效且具有成本效益的方案,用于诊断(全)甲状腺切除术后的暂时性/持续性甲状旁腺功能减退。
我们纳入了237例因各种适应症接受(全)甲状腺切除术且未进行中央区颈部清扫的连续患者。前瞻性地在术后第1天早晨测量血清钙(sCa)和完整甲状旁腺激素(iPTH)水平,以预测长期甲状旁腺代谢情况。在术后第2天早晨重复测量。术后1个月和6个月进行随访。
术后第1天早晨,iPTH≥15 pg/mL(178/237;75%)且sCa>2.0 mmol/L的患者血钙正常,预测甲状旁腺代谢“正常”。237例患者中有33例iPTH水平<10 pg/mL且sCa水平≤2.0 mmol/L(甲状旁腺代谢“紊乱”;14%)。一个“灰色区域”包括甲状旁腺代谢“不确定”的患者,其iPTH水平在10至15 pg/mL之间(26/237;11%)。甲状旁腺代谢“紊乱”和“不确定”的患者给予口服钙和维生素D。术后第二天早晨,这26例患者中有10例(38%)的iPTH转为“正常”,不再给予进一步的钙或维生素D。在随访期间,除2例患者外(“永久性”甲状旁腺功能减退;2/237;0.8%),所有患者的补充钙和维生素D均能够停用。
术后早晨测量iPTH可在≥99%的病例中准确预测术后甲状旁腺功能。这一简单建议在所有外科单位均可行,是识别需要补充钙和维生素D患者的一种高效且具有成本效益的方法。